Viking Global Opportunities Illiquid Investments Sub-Master LP - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 18, 2023, Viking Global Opportunities Illiquid Investments Sub-Master LP's relationship to BridgeBio Pharma, Inc. (BBIO) is TenPercentOwner, and currently has 25,120,991 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BBIO insiders.
Data Source: SEC.
Viking Global Opportunities Illiquid Investments Sub-Master LP - Insider Non-Derivative Transactions at BBIO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 19, 2023 | Sell -- (Common Stock) | 1500000 | 35 | 25120991 |